|
Resolution: standard / high Figure 2.
DCs express an altered costimulatory phenotype in lupus diseased mice. (a) To study DCs, we analyzed the total population of splenocytes in mice 6 to 9 months
old and gated for CD11c+ cells that were negative for the B-cell marker CD19. (b) DCs from mice with lupus (thick dark histograms) express lower levels of CD80, normal
levels of CD86, and higher levels of CD40 than DCs of non-autoimmune mice (grey filled
histograms). The highlighted numbers are the percentages of DCs positive for the indicated
markers and are representative of several mice analyzed and shown in (c-e). The vertical
line delineates the threshold of positivity, set on the isotype control background
less than 1% (dotted histograms). (c-e) Positivity for CD80 (c), CD86 (d), and CD40 (e) in DCs gated as in (a). Each circle
represents the percentage of positive cells in one individual mouse, and the horizontal
bars represent the average of each group. (f,g) Averages and standard deviations of CD40 mean fluorescence intensity for expression
in DCs from mice 6 to 9 months old of the indicated strains. We analyzed four to nine
mice per group in (f) and seven to nine mice per group in (g). Results of the Kruskal-Wallis
test analyses are shown in the graphs (k-w) and the post hoc Mann-Whitney test analyses
are shown below the graphs. N.S. indicates p > 0.05.
Colonna et al. Arthritis Research & Therapy 2006 8:R49 doi:10.1186/ar1911 |